共 175 条
[1]
Walsh D(2017)2016 Updated MASCC/ESMO consensus recommendations: management of nausea and vomiting in advanced cancer Support Care Cancer 25 333-340
[2]
Davis M(2006)An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer Support Care Cancer 14 348-353
[3]
Ripamonti C(2019)The nature of nausea: prevalence, etiology, and treatment in patients with advanced cancer not receiving antineoplastic treatment Support Care Cancer 27 3071-3080
[4]
Bruera E(2013)Olanzapine: palliative medicine update Am J Hosp Palliat Care 30 75-82
[5]
Davies A(1996)Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology 14 87-96
[6]
Molassiotis A(2020)Antiemetics: ASCO Guideline Update J Clin Oncol 38 2782-2797
[7]
Stephenson J(2015)A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients Crit Rev Oncol Hematol 95 214-221
[8]
Davies A(2020)The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature BMC Palliat Care 19 56-532
[9]
Harder S(2002)A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain J Pain Symptom Manag 23 526-255
[10]
Herrstedt J(2003)Olanzapine for intractable nausea in palliative care patients J Palliat Med 6 251-582